206 related articles for article (PubMed ID: 17372899)
1. Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition.
Jenab M; Riboli E; Cleveland RJ; Norat T; Rinaldi S; Nieters A; Biessy C; Tjønneland A; Olsen A; Overvad K; Grønbaek H; Clavel-Chapelon F; Boutron-Ruault MC; Linseisen J; Boeing H; Pischon T; Trichopoulos D; Oikonomou E; Trichopoulou A; Panico S; Vineis P; Berrino F; Tumino R; Masala G; Peters PH; van Gils CH; Bueno-de-Mesquita HB; Ocké MC; Lund E; Mendez MA; Tormo MJ; Barricarte A; Martínez-García C; Dorronsoro M; Quirós JR; Hallmans G; Palmqvist R; Berglund G; Manjer J; Key T; Allen NE; Bingham S; Khaw KT; Cust A; Kaaks R
Int J Cancer; 2007 Jul; 121(2):368-76. PubMed ID: 17372899
[TBL] [Abstract][Full Text] [Related]
2. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.
Kaaks R; Toniolo P; Akhmedkhanov A; Lukanova A; Biessy C; Dechaud H; Rinaldi S; Zeleniuch-Jacquotte A; Shore RE; Riboli E
J Natl Cancer Inst; 2000 Oct; 92(19):1592-600. PubMed ID: 11018095
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk; results from the European prospective investigation into cancer and nutrition.
Cust AE; Allen NE; Rinaldi S; Dossus L; Friedenreich C; Olsen A; Tjønneland A; Overvad K; Clavel-Chapelon F; Boutron-Ruault MC; Linseisen J; Chang-Claude J; Boeing H; Schulz M; Benetou V; Trichopoulou A; Trichopoulos D; Palli D; Berrino F; Tumino R; Mattiello A; Vineis P; Quirós JR; Agudo A; Sánchez MJ; Larrañaga N; Navarro C; Ardanaz E; Bueno-de-Mesquita HB; Peeters PH; van Gils CH; Bingham S; Khaw KT; Key T; Slimani N; Riboli E; Kaaks R
Int J Cancer; 2007 Jun; 120(12):2656-64. PubMed ID: 17285578
[TBL] [Abstract][Full Text] [Related]
4. Plasma insulin, IGF-binding proteins-1 and -2 and risk of colorectal cancer: a prospective study in northern Sweden.
Palmqvist R; Stattin P; Rinaldi S; Biessy C; Stenling R; Riboli E; Hallmans G; Kaaks R
Int J Cancer; 2003 Oct; 107(1):89-93. PubMed ID: 12925961
[TBL] [Abstract][Full Text] [Related]
5. A prospective study of plasma C-peptide and colorectal cancer risk in men.
Ma J; Giovannucci E; Pollak M; Leavitt A; Tao Y; Gaziano JM; Stampfer MJ
J Natl Cancer Inst; 2004 Apr; 96(7):546-53. PubMed ID: 15069117
[TBL] [Abstract][Full Text] [Related]
6. Circulating levels of insulin-like growth factor I, its binding proteins -1,-2, -3, C-peptide and risk of postmenopausal breast cancer.
Keinan-Boker L; Bueno De Mesquita HB; Kaaks R; Van Gils CH; Van Noord PA; Rinaldi S; Riboli E; Seidell JC; Grobbee DE; Peeters PH
Int J Cancer; 2003 Aug; 106(1):90-5. PubMed ID: 12794762
[TBL] [Abstract][Full Text] [Related]
7. Plasma C-peptide, insulin-like growth factor-I, insulin-like growth factor binding proteins and risk of colorectal cancer in a nested case-control study: the Japan public health center-based prospective study.
Otani T; Iwasaki M; Sasazuki S; Inoue M; Tsugane S;
Int J Cancer; 2007 May; 120(9):2007-12. PubMed ID: 17266031
[TBL] [Abstract][Full Text] [Related]
8. A cross-sectional analysis of the associations between adult height, BMI and serum concentrations of IGF-I and IGFBP-1 -2 and -3 in the European Prospective Investigation into Cancer and Nutrition (EPIC).
Crowe FL; Key TJ; Allen NE; Appleby PN; Overvad K; Grønbæk H; Tjønneland A; Halkjær J; Dossus L; Boeing H; Kröger J; Trichopoulou A; Zylis D; Trichopoulos D; Boutron-Ruault MC; de Lauzon-Guillain B; Clavel-Chapelon F; Palli D; Berrino F; Panico S; Tumino R; Sacerdote C; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Gram IT; Rodríguez L; Jakszyn P; Molina-Montes E; Navarro C; Barricarte A; Larrañaga N; Khaw KT; Rodwell S; Rinaldi S; Slimani N; Norat T; Gallo V; Riboli E; Kaaks R
Ann Hum Biol; 2011 Mar; 38(2):194-202. PubMed ID: 20731527
[TBL] [Abstract][Full Text] [Related]
9. Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer.
Lukanova A; Zeleniuch-Jacquotte A; Lundin E; Micheli A; Arslan AA; Rinaldi S; Muti P; Lenner P; Koenig KL; Biessy C; Krogh V; Riboli E; Shore RE; Stattin P; Berrino F; Hallmans G; Toniolo P; Kaaks R
Int J Cancer; 2004 Jan; 108(2):262-8. PubMed ID: 14639613
[TBL] [Abstract][Full Text] [Related]
10. A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women.
Wei EK; Ma J; Pollak MN; Rifai N; Fuchs CS; Hankinson SE; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):850-5. PubMed ID: 15824155
[TBL] [Abstract][Full Text] [Related]
11. Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study.
Stattin P; Bylund A; Rinaldi S; Biessy C; Déchaud H; Stenman UH; Egevad L; Riboli E; Hallmans G; Kaaks R
J Natl Cancer Inst; 2000 Dec; 92(23):1910-7. PubMed ID: 11106682
[TBL] [Abstract][Full Text] [Related]
12. Serum IGF-I, its major binding protein (IGFBP-3) and epithelial ovarian cancer risk: the European Prospective Investigation into Cancer and Nutrition (EPIC).
Peeters PH; Lukanova A; Allen N; Berrino F; Key T; Dossus L; Rinaldi S; van Gils CH; Bueno-de-Mesquita HB; Boeing H; Schulz M; Chang-Claude J; Linseisen J; Panico S; Sacerdote C; Palli D; Tumino R; Trichopoulou A; Trichopolos D; Bamia C; Larranaga N; Ardanaz E; Pera G; Quirós JR; Martínez-García C; Navarro C; Bingham SA; Khaw KT; Clavel F; Tjonneland A; Olsen A; Overvad K; Tetsche MS; Lund E; Lundin E; Berglund G; Riboli E; Kaaks R
Endocr Relat Cancer; 2007 Mar; 14(1):81-90. PubMed ID: 17395977
[TBL] [Abstract][Full Text] [Related]
13. Risk of ovarian cancer in relation to prediagnostic levels of C-peptide, insulin-like growth factor binding proteins-1 and -2 (USA, Sweden, Italy).
Lukanova A; Lundin E; Micheli A; Akhmedkhanov A; Rinaldi S; Muti P; Lenner P; Biessy C; Krogh V; Riboli E; Hallmans G; Berrino F; Zeleniuch-Jacquotte A; Toniolo P; Kaaks R
Cancer Causes Control; 2003 Apr; 14(3):285-92. PubMed ID: 12814208
[TBL] [Abstract][Full Text] [Related]
14. The association between diet and serum concentrations of IGF-I, IGFBP-1, IGFBP-2, and IGFBP-3 in the European Prospective Investigation into Cancer and Nutrition.
Crowe FL; Key TJ; Allen NE; Appleby PN; Roddam A; Overvad K; Grønbaek H; Tjønneland A; Halkjaer J; Dossus L; Boeing H; Kröger J; Trichopoulou A; Dilis V; Trichopoulos D; Boutron-Ruault MC; De Lauzon B; Clavel-Chapelon F; Palli D; Berrino F; Panico S; Tumino R; Sacerdote C; Bueno-de-Mesquita HB; Vrieling A; van Gils CH; Peeters PH; Gram IT; Skeie G; Lund E; Rodríguez L; Jakszyn P; Molina-Montes E; Tormo MJ; Barricarte A; Larrañaga N; Khaw KT; Bingham S; Rinaldi S; Slimani N; Norat T; Gallo V; Riboli E; Kaaks R
Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1333-40. PubMed ID: 19423514
[TBL] [Abstract][Full Text] [Related]
15. Gender difference in the association of insulin and the insulin-like growth factor axis with colorectal neoplasia.
Yamaji T; Iwasaki M; Sasazuki S; Tsugane S
Int J Obes (Lond); 2012 Mar; 36(3):440-7. PubMed ID: 21673650
[TBL] [Abstract][Full Text] [Related]
16. Circulating insulin-like growth factor binding protein-1 and the risk of pancreatic cancer.
Wolpin BM; Michaud DS; Giovannucci EL; Schernhammer ES; Stampfer MJ; Manson JE; Cochrane BB; Rohan TE; Ma J; Pollak MN; Fuchs CS
Cancer Res; 2007 Aug; 67(16):7923-8. PubMed ID: 17699799
[TBL] [Abstract][Full Text] [Related]
17. Plasma insulin-like growth factor 1, insulin-like growth factor binding protein 3, and risk of colorectal cancer: a prospective study in northern Sweden.
Palmqvist R; Hallmans G; Rinaldi S; Biessy C; Stenling R; Riboli E; Kaaks R
Gut; 2002 May; 50(5):642-6. PubMed ID: 11950809
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies.
Rinaldi S; Cleveland R; Norat T; Biessy C; Rohrmann S; Linseisen J; Boeing H; Pischon T; Panico S; Agnoli C; Palli D; Tumino R; Vineis P; Peeters PH; van Gils CH; Bueno-de-Mesquita BH; Vrieling A; Allen NE; Roddam A; Bingham S; Khaw KT; Manjer J; Borgquist S; Dumeaux V; Torhild Gram I; Lund E; Trichopoulou A; Makrygiannis G; Benetou V; Molina E; Donate Suárez I; Barricarte Gurrea A; Gonzalez CA; Tormo MJ; Altzibar JM; Olsen A; Tjonneland A; Grønbaek H; Overvad K; Clavel-Chapelon F; Boutron-Ruault MC; Morois S; Slimani N; Boffetta P; Jenab M; Riboli E; Kaaks R
Int J Cancer; 2010 Apr; 126(7):1702-15. PubMed ID: 19810099
[TBL] [Abstract][Full Text] [Related]
19. Lifestyle and dietary correlates of plasma insulin-like growth factor binding protein-1 (IGFBP-1), leptin, and C-peptide: the Multiethnic Cohort.
DeLellis Henderson K; Rinaldi S; Kaaks R; Kolonel L; Henderson B; Le Marchand L
Nutr Cancer; 2007; 58(2):136-45. PubMed ID: 17640159
[TBL] [Abstract][Full Text] [Related]
20. IGF-I, IGFBP-3 and breast cancer risk in women: The European Prospective Investigation into Cancer and Nutrition (EPIC).
Rinaldi S; Peeters PH; Berrino F; Dossus L; Biessy C; Olsen A; Tjonneland A; Overvad K; Clavel-Chapelon F; Boutron-Ruault MC; Téhard B; Nagel G; Linseisen J; Boeing H; Lahmann PH; Trichopoulou A; Trichopoulos D; Koliva M; Palli D; Panico S; Tumino R; Sacerdote C; van Gils CH; van Noord P; Grobbee DE; Bueno-de-Mesquita HB; Gonzalez CA; Agudo A; Chirlaque MD; Barricarte A; Larrañaga N; Quiros JR; Bingham S; Khaw KT; Key T; Allen NE; Lukanova A; Slimani N; Saracci R; Riboli E; Kaaks R
Endocr Relat Cancer; 2006 Jun; 13(2):593-605. PubMed ID: 16728585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
